retatrutide triple agonist glp-1 gip glucagon phase 2 obesity trial Retatrutide's mechanisms of action retatrutide triple hormone receptor agonist

If youve suffered severe side effects after using a GLP-1 medication, you may wonder if you qualify for legal action

While the outcomes of such early test trials are not binding on other claims, they could help potentially facilitate a GLP-1 settlement agreement that would avoid the need for each individual case to be set for trial in the future

Your diabetes team may recommend: Checking blood glucose before bed and upon waking Adjusting doses of other diabetes medications if hypoglycaemia occurs do not adjust insulin or sulphonylurea doses without personalised guidance from your healthcare team Having a small, appropriate bedtime snack if advised by your healthcare team Sleep hygiene practices remain important, as recommended by the NHS and NICE Clinical Knowledge Summaries: [13] Maintain a regular sleep schedule, even at weekends Create a cool, dark, quiet sleeping environment Establish a relaxing bedtime routine Limit screen time for at least one hour before bed Consider relaxation techniques such as deep breathing or progressive muscle relaxation If you have symptoms of obstructive sleep apnoea (snoring, witnessed breathing pauses, excessive daytime sleepiness), discuss this with your GP as you may need referral for assessment

Exenatide was administered by subcutaneous injection twice a day